Characterizing influenza type A and B virus genomes through whole-genome nanopore sequencing
Influenza is a global health concern, due to annual epidemics of the disease and its potential to cause a pandemic with novel strain variants. Whole-genome sequencing enables ongoing surveillance and identification of new emergent strains, and can therefore provide information to inform the development of seasonal vaccines.
There are two main strains of influenza virus, A and B, that are responsible for seasonal epidemics. This overview describes how to generate accurate whole-genome sequences of influenza A and B viruses by PCR amplification and multiplexed nanopore sequencing. This protocol can be used to sequence up to 96 samples in a single sequencing run and provides rapid access to results.
This content was provided by Oxford Nanopore Technologies
In association with
Submit Your Research to the F1000Research Genomics & Genetics Gateway
Advance the fields of genomics and genetics by publishing your research with the F1000Research Genomics & Genetics Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of rigor and integrity while driving innovation in PCR, sequencing, and genetic analysis.
Join a platform that values transparency, openness, and author control. Submit your research today at F1000Research Genomics & Genetics Gateway.
